In addition to care, CVC complications may be related to clinical factors inherent to COVID-19, since extreme elevations of D-dimers, thrombocytopenia, decreased fibrinogen and prolonged prothrombin time occur, associated with an increase in thromboembolic events. Here, F2 is linked to COVID-19.